ADIM
CROX icon

Alpha DNA Investment Management’s Crocs CROX Stock Holding History

Alpha DNA Investment Management’s Portfolio CROX Stock Details CROX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,097
Closed -$1.45M – 115
2021
Q3 		$1.45M Buy
+10,097
New +$1.39M 0.99% 39
2021
Q2 		– Sell
-8,685
Closed -$698K – 213
2021
Q1 		$698K Buy
8,685
+6,336
+270% +$483K 0.8% 35
2020
Q4 		$147K Buy
+2,349
New +$134K 0.16% 113

Other funds holding CROX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Alpha DNA Investment Management's CROX Position: Q4 2021 in Review

Alpha DNA Investment Management sold out of Crocs (CROX) in Q4 2021, closing a stake of 10,097 shares — an estimated $1.45M sold.

Alpha DNA Investment Management first reported a position in CROX in Q4 2020 and held it in 3 quarters. The position peaked at $1.45M in Q3 2021. 435 funds tracked by Wall St. Rank hold CROX as of Q4 2021.

  • Alpha DNA Investment Management reported no remaining Crocs position as of Q4 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 10,097 Crocs shares in Q4 2021, an estimated $1.45M.
  • Alpha DNA Investment Management first reported a position in Crocs in Q4 2020 and held it in 3 quarters.
  • Alpha DNA Investment Management's Crocs position peaked at $1.45M in Q3 2021.
  • 435 funds tracked by Wall St. Rank held Crocs as of Q4 2021.

Based on Alpha DNA Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.